Adicet Cost Of Revenue from 2010 to 2024

ACET Stock  USD 0.90  0.06  6.25%   
Adicet Bio Cost Of Revenue yearly trend continues to be comparatively stable with very little volatility. Cost Of Revenue will likely drop to about 5.8 M in 2024. From the period from 2010 to 2024, Adicet Bio Cost Of Revenue quarterly data regression had r-value of (0.81) and coefficient of variation of  109.69. View All Fundamentals
 
Cost Of Revenue  
First Reported
2000-03-31
Previous Quarter
1.7 M
Current Value
1.6 M
Quarterly Volatility
54.2 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Adicet Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adicet Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.2 M, Interest Expense of 23.8 K or Selling General Administrative of 34.7 M, as well as many indicators such as Price To Sales Ratio of 12.57, Dividend Yield of 0.0 or PTB Ratio of 0.45. Adicet financial statements analysis is a perfect complement when working with Adicet Bio Valuation or Volatility modules.
  
Check out the analysis of Adicet Bio Correlation against competitors.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.

Latest Adicet Bio's Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of Adicet Bio over the last few years. Cost of Revenue is found on Adicet Bio income statement and represents the costs associated with goods and services Adicet Bio provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Adicet Bio's Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Adicet Bio's overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

Adicet Cost Of Revenue Regression Statistics

Arithmetic Mean175,879,407
Geometric Mean14,299,439
Coefficient Of Variation109.69
Mean Deviation183,987,620
Median6,098,000
Standard Deviation192,914,136
Sample Variance37215.9T
Range411.5M
R-Value(0.81)
Mean Square Error13628.6T
R-Squared0.66
Significance0.0002
Slope(35,043,380)
Total Sum of Squares521022.1T

Adicet Cost Of Revenue History

20245.8 M
20236.1 M
2020M
2019125 K
201880 K
2017 5000.0
2016411.5 M

About Adicet Bio Financial Statements

Adicet Bio shareholders use historical fundamental indicators, such as Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although Adicet Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Adicet Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Adicet Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue6.1 M5.8 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Adicet Stock Analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.